This inventor holds 1 USPTO granted patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Thomas Henry Charpentier: Innovator in G-alpha-Q Signaling
Introduction
Thomas Henry Charpentier is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biochemistry, particularly in the modulation of G-alpha-Q signaling pathways. His work is essential for understanding various cellular processes and has implications for drug development.
Latest Patents
Charpentier holds a patent titled "Methods and compositions for modulating G-alpha-Q signaling." This invention provides compositions and methods for modulating G-alpha-q activity and includes methods for screening test substances that can influence G-alpha-q activity. His innovative approach is crucial for advancing research in this area.
Career Highlights
Charpentier is affiliated with the University of North Carolina at Chapel Hill, where he continues to engage in groundbreaking research. His academic background and expertise have positioned him as a valuable asset in the scientific community.
Collaborations
Throughout his career, Charpentier has collaborated with esteemed colleagues, including Matthew Owen Barrett and Thomas K Harden. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Thomas Henry Charpentier's contributions to the field of G-alpha-Q signaling exemplify the impact of innovative research in biochemistry. His work not only advances scientific understanding but also paves the way for future developments in therapeutic applications.